Treatments for rare diseases can run millions of dollars of costs and governments are often forced to choose whether to fund treatment or put limited resources into initiatives that can help more people.
That’s one of the complex realities Larry Lynd and his team at the Faculty of Pharmaceutical Science, together with the UBC school of journalism, wanted to highlight with the launch of milliondollarmeds.com.
Click here to read the full article from the February 28, 2016 edition of the Vancouver Metro